307 related articles for article (PubMed ID: 28195503)
1. Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: The Malmö Preventive Project.
Berntsson J; Smith JG; Nilsson PM; Hedblad B; Melander O; Engström G
Eur J Prev Cardiol; 2017 May; 24(8):788-795. PubMed ID: 28195503
[TBL] [Abstract][Full Text] [Related]
2. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
3. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
4. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular biomarkers predict fragility fractures in older adults.
Johansson M; Ricci F; Di Martino G; Rogmark C; Sutton R; Hamrefors V; Melander O; Fedorowski A
Heart; 2019 Mar; 105(6):449-454. PubMed ID: 30322844
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.
Holm H; Nägga K; Nilsson ED; Ricci F; Melander O; Hansson O; Bachus E; Magnusson M; Fedorowski A
J Intern Med; 2017 Jul; 282(1):94-101. PubMed ID: 28407377
[TBL] [Abstract][Full Text] [Related]
7. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
[TBL] [Abstract][Full Text] [Related]
8. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
9. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
Charitakis E; Walfridsson H; Alehagen U
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
11. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
De Marchis GM; Schneider J; Weck A; Fluri F; Fladt J; Foerch C; Mueller B; Luft A; Christ-Crain M; Arnold M; Katan M
Neurology; 2018 Feb; 90(6):e455-e465. PubMed ID: 29321236
[TBL] [Abstract][Full Text] [Related]
12. Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
Schweizer J; Arnold M; König IR; Bicvic A; Westphal LP; Schütz V; Inauen C; Scherrer N; Luft A; Galovic M; Ferreira Atuesta C; Pokorny T; Arnold M; Fischer U; Bonati LH; De Marchis GM; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Sagris D; Foerch C; Spanaus K; von Eckardstein A; Katan M
J Am Coll Cardiol; 2022 Apr; 79(14):1369-1381. PubMed ID: 35393018
[TBL] [Abstract][Full Text] [Related]
13. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
[No Abstract] [Full Text] [Related]
14. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
[TBL] [Abstract][Full Text] [Related]
15. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
[TBL] [Abstract][Full Text] [Related]
16. Pro B-type Natriuretic Peptide and Midregional Proadrenomedullin are Associated with Incident Carotid Stenosis During Long Term Follow-up.
Fatemi S; Acosta S; Zarrouk M; Engström G; Melander O; Gottsäter A
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105403. PubMed ID: 33160126
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
[TBL] [Abstract][Full Text] [Related]
18. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
19. Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study.
Schnabel RB; Wild PS; Schulz A; Zeller T; Sinning CR; Wilde S; Kunde J; Lubos E; Lackner KJ; Warnholtz A; Gori T; Blankenberg S; Munzel T;
Hypertension; 2012 Aug; 60(2):288-95. PubMed ID: 22689741
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive Biomarkers Associated With Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality.
Dakhel A; Engström G; Melander O; Acosta S; Fatemi S; Gottsäter A; Zarrouk M
Angiology; 2021 Jul; 72(6):550-555. PubMed ID: 33504164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
